These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 19279027

  • 1. Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
    Valk S, Jordaens L.
    Europace; 2009 Apr; 11(4):407-8. PubMed ID: 19279027
    [No Abstract] [Full Text] [Related]

  • 2. [Primary prevention of sudden cardiac death].
    Reek S, Geller JC, Klein HU.
    Dtsch Med Wochenschr; 2001 Apr 12; 126(15):435-8. PubMed ID: 11347006
    [No Abstract] [Full Text] [Related]

  • 3. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ.
    Circ Cardiovasc Imaging; 2009 May 12; 2(3):183-90. PubMed ID: 19808591
    [Abstract] [Full Text] [Related]

  • 4. Sudden death after myocardial infarction--who needs prophylaxis, and when?
    Buxton AE.
    N Engl J Med; 2005 Jun 23; 352(25):2638-40. PubMed ID: 15972871
    [No Abstract] [Full Text] [Related]

  • 5. Prophylactic implantable cardioverter-defibrillators after myocardial infarction--not for everyone.
    Gillis AM.
    N Engl J Med; 2004 Dec 09; 351(24):2540-2. PubMed ID: 15590957
    [No Abstract] [Full Text] [Related]

  • 6. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB, Xie X, van der Avoort CJ, Dendukuri N, Brophy JM.
    Int J Technol Assess Health Care; 2009 Apr 09; 25(2):151-60. PubMed ID: 19331707
    [Abstract] [Full Text] [Related]

  • 7. Sudden death prevention with implantable devices.
    Passman R, Kadish A.
    Circulation; 2007 Jul 31; 116(5):561-71. PubMed ID: 17664385
    [No Abstract] [Full Text] [Related]

  • 8. Sudden death in patients with myocardial infarction.
    Jacobs AG.
    N Engl J Med; 2005 Sep 22; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180269
    [No Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter-defibrillators after myocardial infarction.
    Myerburg RJ.
    N Engl J Med; 2008 Nov 20; 359(21):2245-53. PubMed ID: 19020326
    [No Abstract] [Full Text] [Related]

  • 10. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
    González CM.
    Arch Cardiol Mex; 2007 Nov 20; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
    [Abstract] [Full Text] [Related]

  • 11. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May 20; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 12. [ICD-implantation--for which patients is its value for primary prevention secure?].
    Fiek M, Reithmann C, Steinbeck G.
    Dtsch Med Wochenschr; 2006 Sep 29; 131(39):2165-8. PubMed ID: 16991035
    [No Abstract] [Full Text] [Related]

  • 13. Is mechanical dispersion a raven of ventricular arrhythmias?
    Zoghbi WA, Narula J.
    JACC Cardiovasc Imaging; 2010 Mar 29; 3(3):330-1. PubMed ID: 20223434
    [No Abstract] [Full Text] [Related]

  • 14. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
    Weintraub WS.
    Circulation; 2001 Sep 25; 104(13):1457-8. PubMed ID: 11571235
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).
    Santini M, Russo M, Botto G, Lunati M, Proclemer A, Schmidt B, Erdogan A, Helmling E, Rauhe W, Desaga M, Santi E, Messier M, Boriani G.
    Europace; 2009 Apr 25; 11(4):476-82. PubMed ID: 19136492
    [Abstract] [Full Text] [Related]

  • 16. Implantable defibrillators and sudden cardiac death.
    Josephson M, Wellens HJ.
    Circulation; 2004 Jun 08; 109(22):2685-91. PubMed ID: 15184292
    [No Abstract] [Full Text] [Related]

  • 17. Are complications of implantable defibrillators under-estimated and benefits over-estimated?
    Brignole M.
    Europace; 2009 Sep 08; 11(9):1129-33. PubMed ID: 19578174
    [No Abstract] [Full Text] [Related]

  • 18. Timing of arrhythmic death after myocardial infarction: does it affect timing of ICD implantation?
    Lombardi F.
    Eur Heart J; 2005 Jul 08; 26(14):1350-2. PubMed ID: 15872027
    [No Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of cardioverter-defibrillators in heart failure patients.
    Gandjour A.
    Europace; 2009 Dec 08; 11(12):1721. PubMed ID: 19880854
    [No Abstract] [Full Text] [Related]

  • 20. Sudden death in patients with myocardial infarction.
    Khera A, Levine BD.
    N Engl J Med; 2005 Sep 22; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180270
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.